Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.400
https://www.valueinhealthjournal.com/article/S1098-3015(16)31767-3/fulltext
Title : Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31767-3&doi=10.1016/j.jval.2016.09.400
First page : A415
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 371
Categories :
Tags :
Regions :
ViH Article Tags :